Bright Minds Biosciences (DRUG) Retained Earnings (2020 - 2026)
For the quarter ending Q1 2026, Retained Earnings changed N/A year-over-year to $5.4 million, compared with a TTM value of $5.4 million through Mar 2026, changed N/A, and an annual FY2025 reading of $3.9 million, up 32.95% over the prior year.
Bright Minds Biosciences (DRUG) has disclosed Retained Earnings for 6 consecutive years, with $5.4 million as the latest value for Q1 2026.
- Retained Earnings reached $5.4 million in Q1 2026 per DRUG's latest filing, up from $3.9 million in the prior quarter.
- Across five years, Retained Earnings topped out at $5.4 million in Q1 2026 and bottomed at -$23.5 million in Q3 2023.
- Average Retained Earnings over 5 years is -$1.9 million, with a median of $2.9 million recorded in 2024.
- Year-over-year, Retained Earnings crashed 1337.79% in 2023 and then surged 112.48% in 2024.
- Bright Minds Biosciences' Retained Earnings stood at $1.9 million in 2022, then tumbled by 1337.79% to -$23.5 million in 2023, then skyrocketed by 112.48% to $2.9 million in 2024, then skyrocketed by 32.95% to $3.9 million in 2025, then soared by 37.39% to $5.4 million in 2026.
- Per Business Quant, the three most recent readings for DRUG's Retained Earnings are $5.4 million (Q1 2026), $3.9 million (Q3 2025), and $2.9 million (Q3 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -211.85 Mn |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -153.89 Mn |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 1.00 Bn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | -438.66 Mn |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -279.00 Mn |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 14.59 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | 36.42 Bn |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 130.89 Mn |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -24.89 Mn |
| 10 | Bright Minds Biosciences | 464.72 Mn | 405.19 Mn | - | 5.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.36 Mn |
| Dec 31, 2025 | -38.83 Mn |
| Sep 30, 2025 | 33.85 Mn |
| Jun 30, 2025 | -30.67 Mn |
| Mar 31, 2025 | -25.96 Mn |
| Dec 31, 2024 | -24.55 Mn |
| Sep 30, 2024 | 2.94 Mn |
| Jun 30, 2024 | -24.55 Mn |
| Mar 31, 2024 | -25.09 Mn |
| Dec 31, 2023 | -24.41 Mn |
| Sep 30, 2023 | -23.53 Mn |
| Jun 30, 2023 | -22.35 Mn |
| Mar 31, 2023 | -21.13 Mn |
| Dec 31, 2022 | -19.53 Mn |
| Sep 30, 2022 | 1.90 Mn |
| Jun 30, 2022 | -16.64 Mn |
| Mar 31, 2022 | -14.65 Mn |
| Dec 31, 2021 | -11.16 Mn |
| Sep 30, 2021 | 1.24 Mn |
| Sep 30, 2020 | 121,043.34 |